Skip to main content
. 2019 Sep 17;8(9):1478. doi: 10.3390/jcm8091478

Figure 2.

Figure 2

Summary of the inclusion criteria considered in patients entering a therapeutic program with blood-based eye drops, graphed in columns where each colour represents a specific product. Numbers in the columns represent the number of studies.